[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
April 1987

Management of the Urinary Tract Involved by Recurrent Cancer

Author Affiliations

From the Departments of Surgery, New England Deaconess Hospital (Drs Eyre, Benotti, Bothe, Cady, and Steele) and Faulkner Hospital (Dr Eyre), Harvard Medical School, Boston.

Arch Surg. 1987;122(4):493-498. doi:10.1001/archsurg.1987.01400160119018
Abstract

• We present our experience from 1982 to the present in treating 33 patients with recurrent cancers (colorectal, 22; gynecologic, six; breast, two; melanoma, two; and lung, one) secondarily involving the genitourinary tract. All patients had severe symptoms that required palliation. Endoscopically placed stents relieved ureteral obstruction in 18 (75%) of 24 patients with widespread metastatic disease. Two patients required percutaneous nephrostomy tubes, and five required open operations. Good to excellent palliation was achieved in 23 of 24 patients. Mean survival in the group with diffuse metastases was 13 months (range, six to 29 months). Nine patients with localized recurrences underwent surgical procedures. For localized pelvic recurrences, total exenteration (with or without intraoperative radiotherapy) provided excellent palliation with low morbidity. At the time of this report, five of six such patients had no evidence of disease, and one had a small asymptomatic pelvic recurrence, with a mean follow-up of 13 months (range, five to 19 months).

(Arch Surg 1987;122:493-498)

References
1.
Brunschwig A:  Complete excision of the pelvic viscera for advanced carcinoma . Cancer 1984;1:177-183.Article
2.
Brunschwig A, Barber HRK:  Surgical treatment of carcinoma of the cervix . Obstet Gynecol 1966;27:21-29.
3.
Kiselow M, Butcher HR, Bricker EM:  Results of the radical surgical treatment of advanced pelvic cancer: A 15-year study . Ann Surg 1967;166: 428-436.
4.
Morley GW, Lindenauer SM, Cerney JC:  Pelvic exenteration therapy in recurrent pelvic carcinoma . Am J Obstet Gynecol 1971;109:1175-1186.
5.
Ulm AH, Klein E:  Management of ureteral obstruction produced by recurrent cancer of the rectosigmoid colon . Surg Gynecol Obstet 1960;110: 413-418.
6.
Richie JP, Withers G, Ehrlich R:  Ureteral obstruction secondary to metastatic tumors . Surg Gynecol Obstet 1979;148:355-357.
7.
Gunderson LL, Cohen AC, Dosoretz DD, et al:  Residual, unresectable, or recurrent colorectal cancer: External beam irradiation and intraoperative electron beam boost ± resection . Int J Radiat Oncol Biol Phys 1983;9:1597-1606.Article
8.
Olsson CA, Deckers PJ, Williams L, et al:  New look at pelvic exenteration . Urology 1976;7:355-361.Article
9.
Sharer W, Grayhack JT, Graham J:  Palliative urinary diversion for malignant ureteral obstruction . J Urol 1978;126:162-164.
10.
Brin EN, Schiff M, Weiss RM:  Palliative urinary diversion for pelvic malignancy . J Urol 1975;113:619-622.
11.
Eyre RC, Rosenthal JT, Libertino JA, et al:  Management of urinary and bowel complications after ileal conduit diversion . J Urol 1982;128:1177-1180.
×